Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with KYNB: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
KYNB
Kyntra Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
KYNB
Kyntra Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,360.67
▼
−0.30%
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
KYNB
Kyntra Bio, Inc.
Change
3.66
0.00%
Regular session
Nov 6 '26
Mkt cap
$14.8M
Revenue
$4M
Q1 FY26
Revenue
$6M
FY25
vs
Compare
Regular session
Nov 6 '26
LLY
ELI Lilly & Co
vs
KYNB
Kyntra Bio, Inc.
1,360.67
▼
−0.30%
Price
3.66
0.00%
$1.2T
Mkt cap
$14.8M
Q3 FY26
$24.4B
Revenue
$4M
Q1 FY26
FY25
$65.2B
Revenue
$6M
FY25
Change
Change
LLY
1,360.67
▼
−0.30%
vs
KYNB
3.66
0.00%
Regular session
Nov 6 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
KYNB: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only KYNB
10
AZN
AstraZeneca AB ("AstraZeneca")
customer
—
Astellas Pharma Inc. ("Astellas")
unlisted
supplier
—
Fortis Therapeutics, Inc. ("Fortis")
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Shanghai SynTheAll Pharmaceutical Co., Ltd. ("WuXi STA")
unlisted
supplier
6 more · KYNB chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
KYNB, dashed